AIHAs may be caused by either IgG or IgM class antibodies which affects the presentation and severity of the hemolytic process. In addition, the IHA may be idiopathic or secondary in etiology. Resolution of underlying diseases in the secondary type will often resolve the hemolysis; however, treatment may require more than one course of action, especially in the WAIHAs.
|Idioma original||English (US)|
|Número de páginas||5|
|Publicación||Clinical laboratory science : journal of the American Society for Medical Technology|
|Estado||Published - mar 1 1999|
ASJC Scopus subject areas
- Biochemistry, Genetics and Molecular Biology(all)